Navigation Links
New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes

rching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. In 2006, Boehringer Ingelheim posted net sales of 10.6 billion euro while spending one fifth of net sales in its largest business segment Prescription Medicines on research and development.

For more information please visit http://www.boehringer-ingelheim.com

Please be advised

This release is from the Corporate Headquarters of Boehringer Ingelheim and is intended for all international markets. This being the case, please be aware that there may be some differences between countries regarding specific medical information including licensed uses. Please take account of this when referring to the material.

<< References

(1) Burgess E et al. Efficacy of telmisartan compared with losartan in reducing proteinuria in hypertensive type 2 diabetic patients with overt nephropathy. Presented at the Annual Meeting of the European Society of Hypertension. June 2007, Milan, Italy.

(2) Hossain P et al. Obesity and Diabetes in the Developing World - a Growing Challenge. NEJM 2007; 356(3):213-215.

(3) Wild S et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047- 53.

(4) US Renal Data System. USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Available at: http://www.usrds.org/atlas.htm">http://www.usrds.org/atlas.htm. Accessed 06-2007.

(5) Yue JL et al. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Ne
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:7/30/2014)... -- Today the US Surgeon General issued the most stern warning ... burns stating they can lead directly to deadly melanoma skin ... says that "skin cancer is a major public health problem ... indoor and outdoor ultraviolet light is a major cause." At ... Boca Raton, Florida , Marta I. Rendon ...
(Date:7/30/2014)... , July 30, 2014 Research ... "Global and Chinese Aseptic Packaging Industry Report 2014" ... http://photos.prnewswire.com/prnh/20130307/600769 The Global and Chinese ... study on the current state of the global Aseptic ... The report provides a basic overview of the ...
(Date:7/30/2014)... 30, 2014  InnoPharma, Inc. today announced the first ... equivalent of Zyprexa® injection), in Canada.  Olanzapine is indicated ... in patients with schizophrenia or bipolar I mania. ... InnoPharma has entered into an agreement with Sandoz Canada ... make, use, sell, market and distribute Olanzapine Injection in ...
Breaking Medicine Technology:Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2Global and Chinese Aseptic Packaging Industry Report 2014 2InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2
... Life Technologies Corporation (NASDAQ: ... an agreement with GlaxoSmithKline Biologicals S.A. (GSK) to develop ... with a GSK candidate cancer immunotherapy. Specifically, Life will ... cancer immunotherapy candidate designed to identify patients likely to ...
... Desert Radiologists has earned Breast MRI accreditation from ... first facility in Las Vegas to receive this prestigious ... that the breast MRI at Desert Radiologists meets ACR,s ... quality control procedures and quality assurance programs. ...
Cached Medicine Technology:Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics 2Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics 3Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics 4Desert Radiologists Earns ACR Breast MRI Accreditation 2
(Date:7/30/2014)... mutationslong known to fuel cancer as well as evolutionary ... rare events that occur randomly throughout the genome. , ... involves the formation of multiple mutations that arise simultaneously ... of clustered mutations are frequently found in regions where ... the journal Cell Reports , may one day ...
(Date:7/30/2014)... Hamilton Facial Plastic Surgery is ... office on July 30th. After months of planning, Dr. ... the state-of-the-art suite, located only steps away from the ... for one-on-one patient comfort, shorter wait times, and generally ... Hamilton’s new office-suite will continue to provide the same ...
(Date:7/30/2014)... NJ. July 30, 2014. A new network of 25 ... Stroke Trials Network (NIH StrokeNet) is working to ... U.S. Despite advances of the last two decades, ... stroke causes death or disability for 795,000 Americans. The ... of the population. , To accelerate the pace ...
(Date:7/30/2014)... 30, 2014 Over 630 doctors worldwide ... Technique®, the revolutionary minimally invasive treatment for gum recession. ... many of his peers to be the “father of ... a recent Chao Pinhole Surgical Technique® training course at ... is the recipient of the American Academy of Periodontics ...
(Date:7/30/2014)... Children’s Hospital of Michigan Foundation and Kohl’s invite ... to 7 p.m. Wednesday, August 6 at the Kohl’s ... 48152). The event will feature Detroit Red Wings defenseman ... and local public safety officials. Kohl’s will present a ... Foundation. , The gift supports Kohl’s Injury Prevention ...
Breaking Medicine News(10 mins):Health News:Biologists describe mechanism promoting multiple DNA mutations 2Health News:Hamilton Facial Plastic Surgery Opens New Carmel Office 2Health News:Kessler funded as satellite site for NIH Stroke Trials Network 2Health News:Periodontist Dr. Dennis Shanelec Comments On The Chao Pinhole Surgical Technique® Training Course 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 3Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 4
... to a,recently published study, frequent mobile phone users ... study investigating the long term,effects of mobile phone ... that,frequent mobile phone users showed better focused attention, ... to making more phone calls in,distractive surroundings. No ...
... Hope, Jewelry Collection Donates 100% of Net Profits to The ... Ovarian Cancer ... commemorates,the 10th anniversary of its partnership with The Ovarian Cancer Research,Fund ... the past decade, L,Oreal Paris has offered hope to the tens ...
... 2007 -- WASHINGTON, DC) The Society for Cardiovascular ... Cardiology (ACC) announced today that they will hold a ... 2008. The meeting will be known as The SCAI ... It will be held concomitantly with the ACC Annual ...
... cases, patients never take these important medications again, study ... American seniors stop taking medications for chronic health problems ... exceed spending limits in their Medicare prescription drug plans, ... nonprofit research organization the RAND Corporation, also found that ...
... Va., Sept. 11 As part of an,initiative ... the cities visited,during its annual scientific meetings, the ... partnering with The Wellness Community -,South Bay Cities ... Volunteers from The Wellness Community will join forces ...
... , TUESDAY, Sept. 11 (HealthDay News) -- Short-term weight ... a new study shows. , Patients who gain as ... few weeks may require hospitalization within the month, according ... than 10 pounds are eight times more likely than ...
Cached Medicine News:Health News:'Slowed Brain-Activity' in Frequent Mobile Phone Users 2Health News:L'Oreal Paris Celebrates Ten Years of Hope and Healing 2Health News:L'Oreal Paris Celebrates Ten Years of Hope and Healing 3Health News:L'Oreal Paris Celebrates Ten Years of Hope and Healing 4Health News:L'Oreal Paris Celebrates Ten Years of Hope and Healing 5Health News:SCAI and ACC announce new interventional cardiology meeting 2Health News:Medicare Spending Caps Cause Seniors to Stop Meds 2Health News:ASTRO, Wellness Community South Bay Cities Join to Promote Cancer Survivorship 2Health News:Weight Gain May Spell Trouble for Heart Failure Patients 2
... providers can code the charge while completing a ... while away from office, both directly feeding the ... an Encounter Form/Superbill, data entry can be done ... patient payments are posted by reflecting open item ...
The CH 2000 Cardiac Diagnostic system is a fully featured stress testing system that can include Microvolt T-Wave Alternans (MTWA) testing capability as an add-on feature. , ,Interfaces with Tra...
The HearTwave system is the original stand-alone Microvolt T-Wave Alternans (MTWA) testing platform....
... features 4 precisely angled 64° mirrors to ... anterior chamber angle with slight rotation. ... element) provides a stable platform during laser ... mirror lens provides a complete view of ...
Medicine Products: